Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Brand Names
Bexsero
Generic Name
Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle
DrugBank Accession Number
DB10786
Background

Not Available

Type
Biotech
Groups
Approved
Biologic Classification
Vaccines
Other vaccines
Synonyms
Not Available

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
BexseroNeisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle (25 ug/0.5mL) + Neisseria meningitidis serogroup b fhbp fusion protein antigen (50 ug/0.5mL) + Neisseria meningitidis serogroup b nada protein antigen (50 ug/0.5mL) + Neisseria meningitidis serogroup b nhba fusion protein antigen (50 ug/0.5mL)Injection, suspensionIntramuscularNovartis Vaccines And Diagnostics Srl2015-01-232017-10-31US flag
BexseroNeisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle (25 mcg/0.5ml) + Neisseria meningitidis serogroup b fhbp fusion protein antigen (50 mcg/0.5ml) + Neisseria meningitidis serogroup b nada protein antigen (50 mcg/0.5ml) + Neisseria meningitidis serogroup b nhba fusion protein antigen (50 mcg/0.5ml)Injection, suspensionIntramuscularGsk Vaccines S.R.L.2021-03-01Not applicableEU flag
BexseroNeisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle (25 mcg/0.5ml) + Neisseria meningitidis serogroup b fhbp fusion protein antigen (50 mcg/0.5ml) + Neisseria meningitidis serogroup b nada protein antigen (50 mcg/0.5ml) + Neisseria meningitidis serogroup b nhba fusion protein antigen (50 mcg/0.5ml)Injection, suspensionIntramuscularGsk Vaccines S.R.L.2021-02-08Not applicableEU flag
BEXSERONeisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle (25 mcg) + Neisseria meningitidis serogroup b fhbp fusion protein antigen (50 mcg) + Neisseria meningitidis serogroup b nada protein antigen (50 mcg) + Neisseria meningitidis serogroup b nhba fusion protein antigen (50 mcg)Injection, suspensionIntramuscularGlaxosmithkline Vaccines S.R.L.2014-07-08Not applicableItaly flag
BexseroNeisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle (25 mcg/0.5mL) + Neisseria meningitidis serogroup b fhbp fusion protein antigen (50 mcg/0.5mL) + Neisseria meningitidis serogroup b nada protein antigen (50 mcg/0.5mL) + Neisseria meningitidis serogroup b nhba fusion protein antigen (50 mcg/0.5mL)SuspensionIntramuscularGlaxosmithkline Inc2014-02-26Not applicableCanada flag

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
91523M4S24
CAS number
Not Available

References

General References
Not Available
RxNav
1601236

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedBasic ScienceMeningitis1
4CompletedHealth Services ResearchHealthy Volunteers (HV)1
4CompletedOtherMeningococcal Meningitis1
4CompletedOtherMeningococcal Serogroup B1
4CompletedPreventionInfants, Premature / Meningococcal Disease / Vaccinations1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, suspensionIntramuscular
SuspensionIntramuscular
Injection, solutionIntramuscular
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at December 01, 2015 20:04 / Updated at June 12, 2020 16:53